Cardiology

When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?

Can you provide more clarity for 37215?

As a follow-up to last week’s question, if an embolic protection device cannot be used, which code do we report between the two?

When are codes 37215 and 37216 assigned?

For revascularization codes, what modifiers should be assigned if the tibial/peroneal arteries in both legs are treated?

What impact do the recent CMS updates to the Conditions of Participation (CoP) and Outpatient Prospective Payment System (OPPS) have on emergency preparedness and cardiac care, particularly in hospitals and Critical Access Hospitals?

What new payment policy is CMS implementing to support the use of domestically sourced Mo-99 in nuclear cardiology imaging?

Can you explain how CMS is addressing reimbursement for high-cost diagnostic radiopharmaceuticals used in nuclear cardiology?

What steps is CMS taking to improve access to high-cost specialty drugs, particularly for underserved populations served by Indian Health Service and tribal hospitals?

CMS just finalized a policy to pay for non-opioid pain treatments. Why does this matter, especially for heart patients?

What recent change has CMS made regarding Intensive Outpatient Programs (IOPs), and how does it impact treatment options for patients with opioid use disorder (OUD) and cardiovascular conditions?

What does the CMS market basket adjustment mean for OPPS payments in 2025?